Jewish mystical movements and the european ergot epidemics

Israel Journal of Psychiatry and Related Sciences

Volumn 35, Issue 3, 1998, Pages 227-241

  Packer, Sharon ^a  

^a NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; EPIDEMIC; ERGOTISM; EUROPE; HISTORY; HUMAN; MYSTICISM; RELIGION;

DISEASE OUTBREAKS; ERGOTISM; EUROPE; HISTORY, 17TH CENTURY; HISTORY, 18TH CENTURY; HISTORY, 19TH CENTURY; HISTORY, 20TH CENTURY; HISTORY, MEDIEVAL; HUMANS; JUDAISM; MYSTICISM; RELIGION AND MEDICINE;

EID: 0032239314     PISSN: 03337308     EISSN: 26172402     Source Type: Journal    
DOI: None     Document Type: Article

References (62)

1. Barger G, Ergot and ergotism. London: Gurney & Jackson, 1931.
2. Berde B, Schilde HO, Ergot alkaloids. New York: Springer, Verlag, 1978.
3. Bove FJ, The story of ergot. New York: Barger, 1970.
4. Hanlon JJ, Public health. Sixth Edition. St. Louis: CV Mosby Co., 1974.
5. Last J, editor, Public health and preventative medicine. Eleventh Edition. New York: Appelton-Century-Crofts, 1980.
6. Lorenz K, Ergot on cereal grains. CRC Crit Rev Food Sei Nutr 1979; 11:3111 -3154.
7. Mantle PG, Chemistry of claviceps mycotoxins. In: Wyllie TD, Morehouse LG, editors. Mycotoxic fungi, mycotoxins, mycotoxicoses, Vol. 1 New York: Marcel Dekker, 1977:421-427.
8. Van Zwanenberg D, Ergot epidemics. Med Hist 1973; 17:204-214.
9. Matossian MK, Poisons of the past. New Haven: Yale University, 1989.
10. Nigal G, Magic, mysticism, and hasidism. New Jersey: Aronson, 1994.
11. Goodman LS, Oilman AG, The pharmacological basic of therapeutics (4th Edition). New York: Macmillan, 1970:557-559.
12. Meyers FH, Jawetz E, Goldfien A, Medical pharmacology. California: Lange Medical Publications, 1970:119.
13. Mueller-Schweinitzer E, What is known about the action of dihydrogergotamine on the vasculature in man? Int J Clinical Pharmacology, Therapeutics, and Toxicology 1984:12:677-682.
14. Dige-Petersen H, Noer I, Lassen NA, Tonnesen KH, Subclinical ergotism. Lancet 1977; 2:65-66.
15. Gabbai E, Ergot poisoning at Pont St. Esprit. BMJ 1951:2:650-651.
16. Allbutt TC, Rolleston HD, System of medicine by many writers, New edition, NY, MacMilliam Company, 1897, pp. 793-800, p. 806.
17. Devitt RE, Chater E, Colbert DS, Ergot poisoning. J Irish Med Association 1970; 63:441-444.
18. Iffy L, Lindenthal J, Szod Z, Puerperal psychosis following ablactation with bromocriptine. Medicine & Law;1998;8:171174.
19. Parks D, Mechanisms of bromocriptine-induced hallucinations. N Eng J Med 1982; 302:1479.
20. Packer S, Ergotism in lethal catatonia. Am J Psychiatry 1989; 10:1360.
21. Jahrmaerker M, Zur Frankenberger ergotismusepidemie und liber bleidede folgen des ergotismus fur das centralnervensystem. Arch f. Psychiatrie u. Nervenkrankheiten 1902;35:109-152.
22. American Psychiatric Association, Diagnostic and Statistical Manual of Mental Disorders. Revised Edition, Washington, DC: American Psychiatric Assoc, 1987.
23. Oppenheim H, Zur psychopathologie und nosologie der russich-judischen bevölkeruhg. Journal fur Psychologies & Neurologie 1908;13:l-9.
24. Oilman S, Jews and mental illness. J Hist Beh Sei 1984;20:150-159.
25. Dotz W, St. Anthony's fire. Am J Dermatopathology 1980;2:249-253.
26. Tarnower A, Alguire P, Ergotism masquerading as arteritis. Postgrad Med 1989;85: 103-104.
27. Kaunitz J, The pathological similarity of thrombo-angiitis obliterans and endemic ergotism. Am J Path 1930;6:299-316.
28. Lie JT, Vasculitis simulators and vasculitis look-alikes. Current Opinion in Rheumatology 1992;4:47-55.
29. Taubert G, Sebona T, Histological examination of blood vessels in peripheral gangrene among patients with sporadic outbreak of ergotism. Tropical Geogr Med 1990;42:5862.
30. Dilling WJ, Kelly RE, Gangrene following the use of ergotized rye bread. BMJ 1928;! : 540-542.
31. Merhoff GC, Porter JM, Ergot intoxication: Historical review and description of unusual clinical manifestations. Ann Surg 1974; 1800:773-779.
32. Ward CD, Thompson J, Humby MD, Pleuropulmonary and retroperitoneal fibrosis associated with bromocriptine treatment (letter) 1987;50:1706-1707.
33. Hauck AJ, Edwards WD, Danielson GK, Mitral and aortic value disease associated with ergotamine therapy for migraine. Archives Pathol Laboratory Medicine 1990; 114:62-64.
34. Pier AC, Advances in veterinary science and comparative medicine. Mycotoxins and Animal Health 1981 ;25:185-243.
35. Engel G, Ergotism and art (lecture sponsored by Sandoz Pharmaceutical Company), Pharmacology Department, Mount Sinai School of Medicine, 1989.
36. Hirsch A (translated by Creighton), Handbook of geographical and historical pathology. London, pp. 140-150. Vol. 2, 1883.
37. Morgan MT, Report of an outbreak of alleged ergot poisoning by rye bread in Manchester. J Hygiene 1929;29:51-61.
38. Robertson J, Ashby HT, Ergot poisoning among rye bread consumers. BMJ 1928; 1:302-303.
39. Kohn GC, editor: Plague and pestilence, New York: Facts on File, 1995:275-276.
40. Wasson RG, Kramrisch S, Ott J, Ruck C, Persephone's quest: Entheogens and the origin of religion. New Haven: Yale University, 1986.
41. Dukes J, Medicinal herbs. New York: Trado Medic Books, 1983.
42. Massey JM, Massey EW, Ergot, the "jerks" and revivals. Clinical Neuropharmacology 1984;7:99-109.
43. Matossian MK: Religious revivals and ergotism in America, Clio Medica 1982;16:185192.
44. Aaronson S, Paspalum Spp. and claviceps paspali in ancient and modern India. J Ethnopharmacology 1988;24:345-348.
45. Wolf son ER, Through a speculum that shines. Princeton: Princeton University, 1994.
46. Scholem G, Major trends in Jewish mysticism. Jerusalem: Schocken, 1951.
47. Scholem G, Sabbatai Sévi. New Jersey: Princeton University, 1977.
48. Mahler R, Hasidism and the Jewish enlightenment. Philadelphia/New York: Jewish Publication Society, 1985.
49. Ruderman DB, Kabbalah, magic and science. Cambridge, Mass.: Harvard, 1989.
50. Sh'moneh Esrai (18 Benedictions), In: Sefer Avodath Israel, Baer S, editor. Heideheim: Roedelheim, 1868:89.
51. Ostow M, Judaism and psychoanalysis. New York: Ktav, 1982.
52. Ben Amos D, Mintz JR, In praise of the Baal Shem Tov. New Jersey: Jason Aronson, 1993.
53. Green A, Tormented master: The life of Rabbi Nachman of Bratzlav. New York: Schocken Books, 1986.
54. Dubnow S, Toldot HaHasidut. Tel Aviv: Dvir, 1929:118.
55. Greenberg D, Witztum E, Content and prevalence of psychopathology in world religions. In: Shumaker JF, editor. Religion and mental health, Oxford: Oxford University, 1992.
56. Adams RD, Victor M, Principles of neurology, Third Edition. New York: McGraw Hill, 1985.
57. Roberts J, Guberman A, Religion and epilepsy. Psychiatr J Univ Ottawa 1989; 14.
58. Greenberg DB, Hockberry FH, Marray GB, The theme of death in complex partial seizures. Am J Psychiatry 1984;12:1587-1589.
59. Tucker DM, Novelly RA, Walker PJ, Hyperreligiosity in temporal lobe epilepsy: Redefining the relationship. J Nerv Ment Dis 1976;176:181-183.
60. Gormezano I, Harvey JA, Analysis of hallucinogens by means of Pavlovian conditioning. In: Stillman RC, Willette RC, editors. The psychopharmacology of hallucinogens. New York: Pergamon, 1978.
61. Aaronson B, Osmond H, Psychedelics. New York: Doubleday, 1970.
62. Serby M, Angrist B, Lieberman A, Mental disturbances during bromocriptine and lergotrile treatment of Parkinson's disease. Am J Psychiatry 1978; 135:1227-1229.